“treatment resistant depression”的搜索结果，显示 211-220 项，共有 7733 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

3. 血液科- 临床试验- 妙佑医疗国际

   ... refractory (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment, post-treatment and (when available) ... resistance to 131I-MIBG and crizotinib. Assessing ... therapy are unknown. In addition, relatively ...

6. 外科 - 临床试验- 妙佑医疗国际

   ... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...

7. 脑深部刺激- 医生与科室- 妙佑医疗国际

   Remore LG, et al. Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression: A systematic review focused on the long-term ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

9. 血液科- 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. Testing The Addition Of MEDI4736 (Durvalumab) To ...